Enhancement of cell-mediated immunity in melanoma patients immunized with murine anti-idiotypic monoclonal antibodies (MELIMMUNE) that mimic the high molecular weight proteoglycan antigen.

MLA

Pride, M. W., et al. “Enhancement of Cell-Mediated Immunity in Melanoma Patients Immunized with Murine Anti-Idiotypic Monoclonal Antibodies (MELIMMUNE) That Mimic the High Molecular Weight Proteoglycan Antigen.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 4, no. 10, Oct. 1998, pp. 2363–70. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=9796966&authtype=sso&custid=ns315887.

APA

Pride, M. W., Shuey, S., Grillo-Lopez, A., Braslawsky, G., Ross, M., Legha, S. S., Eton, O., Buzaid, A., Ioannides, C., & Murray, J. L. (1998). Enhancement of cell-mediated immunity in melanoma patients immunized with murine anti-idiotypic monoclonal antibodies (MELIMMUNE) that mimic the high molecular weight proteoglycan antigen. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 4(10), 2363–2370.

Chicago

Pride, M W, S Shuey, A Grillo-Lopez, G Braslawsky, M Ross, S S Legha, O Eton, A Buzaid, C Ioannides, and J L Murray. 1998. “Enhancement of Cell-Mediated Immunity in Melanoma Patients Immunized with Murine Anti-Idiotypic Monoclonal Antibodies (MELIMMUNE) That Mimic the High Molecular Weight Proteoglycan Antigen.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 4 (10): 2363–70. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=9796966&authtype=sso&custid=ns315887.